Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

Overview of attention for article published in Clinical Cancer Research, October 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 17,708)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 53 news outlets
blogs: 4 blogs
twitter: 226 X users

facebook: 5 Facebook pages
wikipedia: 5 Wikipedia pages
reddit: 4 Redditors

Readers on

mendeley: 89 Mendeley

So far, Altmetric has seen 5 posts from 4 blogs.

NEWSSTAND – July 2019

Blog posts – Worldwide Cancer Research, 02 Aug 2019

Eating crickets probably won’t stop you getting…

How A Common Cold Virus Was Used To Defeat Bladder Cancer

ReliaWire, 09 Jul 2019

Non-muscle invasive bladder cancer is the tenth most common cancer in the UK and is difficult to treat. Current treatments are…

How A Common Cold Virus Was Used To Defeat Bladder Cancer

ReliaWire, 09 Jul 2019

Non-muscle invasive bladder cancer is the tenth most common cancer in the UK and is difficult to treat. Current treatments are…

Un virus del raffreddore può uccidere il cancro alla vescica: testata terapia rivoluzionaria

Scienze fanpage, 05 Jul 2019

Il cancro alla vescica può essere attaccato e ucciso da un comunissimo virus del raffreddore, il coxsackievirus (CVA21). Un…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 1 additional blog posts.